Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Posner

Showing results (231-240 of 247) with videos related to

Pageof 25
Sort By:
Head & Neck|April 16, 2016
Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypesIndu Varier, Brieze R Keeley, Rosemarie Krupar, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 20, 2001
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodiesR M Ruprecht, R Hofmann-Lehmann, B A Smith-Franklin, et al.
Nature Communications|June 20, 2014
Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patientsMichael Jeffrey Cho, Agnes S Y Lo, Xuming Mao, et al.
Journal of Medical Primatology|September 14, 2001
Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?R Hofmann-Lehmann, R A Rasmussen, J Vlasak, et al.
Journal of Virology|July 20, 2001
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challengeR Hofmann-Lehmann, J Vlasak, R A Rasmussen, et al.
Oral Oncology|June 15, 2024
Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillanceScott A Roof, James Jabalee, Eleni M Rettig, et al.
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2023
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer SurveillanceGlenn J Hanna, Scott A Roof, Jamie Jabalee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservationM R Posner, C M Norris, L J Wirth, et al.
Science Advances|May 28, 2019
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancerErdem Bangi, Celina Ang, Peter Smibert, et al.
Pageof 25

Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Head & Neck|April 16, 2016
Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypesIndu Varier, Brieze R Keeley, Rosemarie Krupar, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 20, 2001
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodiesR M Ruprecht, R Hofmann-Lehmann, B A Smith-Franklin, et al.
Nature Communications|June 20, 2014
Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patientsMichael Jeffrey Cho, Agnes S Y Lo, Xuming Mao, et al.
Journal of Medical Primatology|September 14, 2001
Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?R Hofmann-Lehmann, R A Rasmussen, J Vlasak, et al.
Journal of Virology|July 20, 2001
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challengeR Hofmann-Lehmann, J Vlasak, R A Rasmussen, et al.
Oral Oncology|June 15, 2024
Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillanceScott A Roof, James Jabalee, Eleni M Rettig, et al.
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2023
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer SurveillanceGlenn J Hanna, Scott A Roof, Jamie Jabalee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservationM R Posner, C M Norris, L J Wirth, et al.
Science Advances|May 28, 2019
A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancerErdem Bangi, Celina Ang, Peter Smibert, et al.
Pageof 25